Suggested guidelines for monitoring liver toxicity in rheumatoid arthritis patients treated with methotrexate: comment on the article by kremer et al
- 9 December 1994
- journal article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 37 (12), 1829-1830
- https://doi.org/10.1002/art.1780371221
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Methotrexate for Rheumatoid ArthritisArthritis & Rheumatism, 1994
- Practice and complications of liver biopsyDigestive Diseases and Sciences, 1993
- Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritisArthritis & Rheumatism, 1993
- Outcome of Patients Hospitalized for Complications after Outpatient Liver BiopsyAnnals of Internal Medicine, 1993
- Complications associated with percutaneous needle biopsy of the liver when one, two or three specimens are takenPublished by Oxford University Press (OUP) ,1992
- Aspirin, hydroxychloroquine, and hepatic enzyme abnormalities with methotrexate in rheumatoid arthritisArthritis & Rheumatism, 1990
- Complications following percutaneous liver biopsyJournal of Hepatology, 1986